<DOC>
	<DOCNO>NCT01907477</DOCNO>
	<brief_summary>The aim present work study protein expression profile neutropenic patient ( high risk invasive mycosis ) develop - versus develop invasive mycosis ( principally aspergillosis candidosis ) order identify biomarkers diagnosis , prognosis /or prediction invasive mycosis .</brief_summary>
	<brief_title>Identification Serum and/or Plasma Biomarkers Diagnosis Prognosis and/or Prediction Invasive Mycosis Neutropenic Patients</brief_title>
	<detailed_description />
	<criteria>Patients malignant haemopathy receive chemotherapy likely lead severe neutropenia ( PN &lt; 500/mm3 ) foreseeable period 10 day . Patients age 14 year old ( upper age limit ) Patients malignant haemopathy receive autologous marrow graft . Patients severe idiopathic medullar aplasia ( PN &lt; 500/mm3 ) need hospitalise least 10 day consecutively ( without immunosuppressant treatment ) . Patients provide write informed consent participate study . Patients receive allograft marrow hematopoietic stem cell transplant ( give patient carry risk aspergillosis , case appear medullar recovery , include study ) . Patients receive autologous hematopoietic stem cell transplant ( give duration neutropenia often less 10 day ) . Patients meet inclusion criterion Persons cover national Health Insurance Agency</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>